CBD LoveThe independent Australian guideSearch

CBD and brain health

Claims that CBD protects the brain come from laboratory and animal studies. No human trial shows CBD prevents or slows any brain disease.

Facts checked 13 November 20265 min readHow we research
Not enough evidence

The evidence is laboratory and animal work only. No human trial showing that CBD prevents or slows any neurodegenerative disease was found, so no protective dose has been tested in people.

How we grade evidence

There is no human evidence that CBD protects the brain. The claim comes from laboratory and animal studies. No trial in people has shown that CBD prevents or slows dementia, Parkinson’s disease or any other brain disease.

What the research shows

“Neuroprotection” means protecting nerve cells from damage or death. A neurodegenerative disease is one where nerve cells are gradually lost, such as Alzheimer’s disease or Parkinson’s disease.

Scientific reviews describe neuroprotective activity for cannabinoids “in preclinical models”.1 Preclinical means before human testing: experiments on cells in a dish and on animals. This is real and useful science. It is also the stage at which most treatments that look effective later fail in people. Our page on how we grade evidence explains why animal and laboratory studies sit at the bottom of the evidence ranking.

No human trial showing that CBD prevents or slows any neurodegenerative disease was found in our research. That is why the grade is “not enough evidence”.

What human trials in brain diseases have found

Where CBD has been tested in people with brain diseases, the trials have looked at symptoms, not at protection, and outside epilepsy none has shown a benefit.

Condition What human trials found Page
Parkinson’s disease In 21 people, CBD at 75 or 300 mg a day made no difference to movement scores.2 Parkinson’s disease
Dementia No completed trial of CBD alone. A THC-free CBD trial for agitation is registered with no results found.3 Dementia
Multiple sclerosis No trial of CBD alone for spasticity. The evidence is for products containing THC.4 Multiple sclerosis
Rare severe epilepsies Strong evidence that high-dose prescription CBD reduces seizures.5 Epilepsy

Epilepsy is the exception that shows CBD can act on the human brain. In a trial of 120 children and young adults with Dravet syndrome, the median number of convulsive seizures a month fell from 12.4 to 5.9 with CBD at 20 mg per kilogram of body weight a day, compared with 14.9 to 14.1 on placebo.5 Reducing seizures is a different thing from protecting nerve cells from a degenerative disease, and the epilepsy trials do not show the latter.

How CBD might act

Researchers have proposed more than 65 molecular targets for CBD.6 The World Health Organization’s review put the uncertainty plainly: “It is not clear which, if any, of these mechanisms are responsible for any of CBD’s potential clinical or other effects.”7 A plausible mechanism is a reason to run trials. It is not evidence of benefit. See how CBD works in the body.

What doses were tested

No dose of CBD has been tested for brain protection in people, because no such human trial was found.

The doses that reduced seizures in trials are large: 10 to 20 mg per kilogram of body weight a day for Dravet and Lennox-Gastaut syndromes, which is roughly 700 to 1,400 mg a day for a 70 kg person.8 Nothing suggests that the much smaller amounts in consumer products overseas protect the brain.

What Australian medical bodies say

No Australian medical body recommends CBD for brain health or to prevent brain disease.

  • The TGA says medicinal cannabis should be considered only when registered medicines have been tried and have failed.9
  • RACGP (the GPs’ college) calls the evidence “limited and inconclusive” and does not recommend or encourage medicinal cannabis.10
  • The only CBD medicine registered in Australia is Epidyolex, for seizures in Lennox-Gastaut syndrome and Dravet syndrome from age 2.11

Risks to know about

Prevention means taking something for years while you are well. That makes side effects matter more, because there is no proven benefit to weigh them against.

  • Liver. In a 4-week study of healthy adults taking about 350 to 400 mg a day, 5.6% had significant liver enzyme rises, compared with none on placebo. They had no symptoms, and levels returned to normal within 1 to 2 weeks of stopping.12 Data at 150 mg a day or less are sparse. See CBD and the liver.
  • Interactions. CBD blocks several liver enzymes that process other medicines.8 See CBD drug interactions.
  • Sleepiness. Drowsiness is among the most common side effects.8
  • Long-term unknowns. The UK Food Standards Agency advises healthy adults to limit CBD from food supplements to 10 mg a day, mainly because of liver effects and sleepiness with long-term use.13

If you are considering it

  • If you are worried about memory or a family history of brain disease, raise that with your GP. Ask what is known to lower risk.
  • If you have a diagnosed neurological condition, ask your specialist what trials exist for that condition specifically.
  • Be wary of any seller claiming CBD “protects” or “supports” the brain. In Australia CBD is a prescription medicine, and such claims are not backed by human trials.

See CBD myths and misleading claims and talking to your GP about CBD.

Footnotes

  1. Review of minor cannabinoids, including preclinical neuroprotection. https://pmc.ncbi.nlm.nih.gov/articles/PMC13516590/ ↩

  2. Chagas MHN et al. Effects of cannabidiol in the treatment of patients with Parkinson’s disease: an exploratory double-blind trial, 2014. https://pubmed.ncbi.nlm.nih.gov/25237116/ ↩

  3. ClinicalTrials.gov. Registered trial of cannabidiol for agitation in Alzheimer’s disease, NCT04436081. https://clinicaltrials.gov/study/NCT04436081 ↩

  4. Filippini G et al. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis. Cochrane review, 2022. https://pubmed.ncbi.nlm.nih.gov/35510826/ ↩

  5. Devinsky O et al. Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. New England Journal of Medicine, 2017. https://doi.org/10.1056/NEJMoa1611618 ↩ ↩2

  6. Review of the molecular targets of cannabidiol. https://pmc.ncbi.nlm.nih.gov/articles/PMC7652785/ ↩

  7. World Health Organization Expert Committee on Drug Dependence. Cannabidiol (CBD) critical review report, 2018. https://cdn.who.int/media/docs/default-source/controlled-substances/whocbdreportmay2018-2.pdf ↩

  8. Epidiolex (cannabidiol) US prescribing information, DailyMed, revised 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bf27097-4870-43fb-94f0-f3d0871d1eec ↩ ↩2 ↩3

  9. Therapeutic Goods Administration. Guidance for the use of medicinal cannabis in Australia: overview. https://www.tga.gov.au/resources/resource/guidance/guidance-use-medicinal-cannabis-australia-overview ↩

  10. Royal Australian College of General Practitioners. Medical cannabis position statement (2019 update). https://www.racgp.org.au/advocacy/position-statements/view-all-position-statements/clinical-and-practice-management/medical-cannabis ↩

  11. Therapeutic Goods Administration. Epidyolex (cannabidiol), Australian prescription medicine decision summary. https://www.tga.gov.au/resources/auspmd/epidyolex ↩

  12. News release on Florian J et al., JAMA Internal Medicine, 2025: liver enzyme elevations in healthy adults taking cannabidiol (secondary report). https://www.eurekalert.org/news-releases/1089832 ↩

  13. UK Food Standards Agency. Provisional cannabidiol (CBD) acceptable daily intake: lay summary. https://www.gov.uk/government/publications/provisional-cannabidiol-cbd-acceptable-daily-intake-adi/lay-summary ↩

Common questions

Does CBD protect the brain?

That has not been shown in people. Reviews describe neuroprotective activity for cannabinoids in preclinical models, which means cells and animals. No human trial was found showing CBD prevents or slows any brain disease.

Is CBD a nootropic that improves memory or focus?

No trial evidence supports that. In a Parkinson's disease trial where thinking and memory were the main outcome, CBD did not differ from placebo. Sleepiness is one of the most common side effects of CBD.

Should I take CBD daily to prevent dementia?

There is no evidence that this works, and no human trial has tested it. Daily long-term use has its own risks, including liver enzyme rises at higher doses and interactions with other medicines. Talk to your GP about proven ways to lower dementia risk.

Does CBD help after a concussion or stroke?

No human trial of CBD for concussion, brain injury or stroke recovery was found in our research. These claims rest on animal and laboratory studies.

This page is general information, not medical or legal advice. Laws and evidence change; we show the date we last checked the facts at the top of every page. Talk to your doctor or pharmacist before starting, stopping or changing any medicine.

Didn't find what you needed? Ask us a question.

Keep reading